The Impact of Cardiovascular Risk Factors on the Course of COVID-19
Aim of the study: The aim of our review is to indicate and discuss the impact of cardiovascular risk factors, such as obesity, diabetes, lipid profile, hypertension and smoking on the course and mortality of COVID-19 infection. Background: The coronavirus disease 2019 (COVID-19) pandemic is spreadin...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/11/8/2250 |
| _version_ | 1797434481088397312 |
|---|---|
| author | Katarzyna Wilk-Sledziewska Piotr Jan Sielatycki Natalia Uscinska Elżbieta Bujno Mariusz Rosolowski Katarzyna Kakareko Rafal Sledziewski Alicja Rydzewska-Rosolowska Tomasz Hryszko Edyta Zbroch |
| author_facet | Katarzyna Wilk-Sledziewska Piotr Jan Sielatycki Natalia Uscinska Elżbieta Bujno Mariusz Rosolowski Katarzyna Kakareko Rafal Sledziewski Alicja Rydzewska-Rosolowska Tomasz Hryszko Edyta Zbroch |
| author_sort | Katarzyna Wilk-Sledziewska |
| collection | DOAJ |
| description | Aim of the study: The aim of our review is to indicate and discuss the impact of cardiovascular risk factors, such as obesity, diabetes, lipid profile, hypertension and smoking on the course and mortality of COVID-19 infection. Background: The coronavirus disease 2019 (COVID-19) pandemic is spreading around the world and becoming a major public health crisis. All coronaviruses are known to affect the cardiovascular system. There is a strong correlation between cardiovascular risk factors and severe clinical complications, including death in COVID-19 patients. All the above-mentioned risk factors are widespread and constitute a significant worldwide health problem. Some of them are modifiable and the awareness of their connection with the COVID-19 progress may have a crucial impact on the current and possible upcoming infection. Data collection: We searched for research papers describing the impact of selected cardiovascular risk factors on the course, severity, complications and mortality of COVID-19 infection form PubMed and Google Scholar databases. Using terms, for example: “COVID-19 cardiovascular disease mortality”, “COVID-19 hypertension/diabetes mellitus/obesity/dyslipidemia”, “cardiovascular risk factors COVID-19 mortality” and other related terms listed in each subtitle. The publications were selected according to the time of their publications between January 2020 and December 2021. From the PubMed database we obtain 1552 results. Further studies were sought by manually searching reference lists of the relevant articles. Relevant articles were selected based on their title, abstract or full text. Articles were excluded if they were clearly related to another subject matter or were not published in English. The types of articles are mainly randomized controlled trial and systematic review. An additional criterion used by researchers was co-morbidities and age of patients in study groups. From a review of the publications, 105 of them were selected for this work with all subheadings included. Findings and Results: The intention of this review was to summarize current knowledge about comorbidities and development of COVID-19 infection. We tried to focus on the course and mortality of the abovementioned virus disease in patients with concomitant CV risk factors. Unfortunately, we were unable to assess the quality of data in screened papers and studies we choose because of the heterogenicity of the groups. The conducted studies had different endpoints and included different groups of patients in terms of nationality, age, race and clinical status. We decide to divide the main subjects of the research into separately described subtitles such as obesity, lipid profile, hypertension, diabetes, smoking. We believe that the studies we included and gathered are very interesting and show modern and present-day clinical data and approaches to COVID-19 infection in specific divisions of patients. |
| first_indexed | 2024-03-09T10:32:49Z |
| format | Article |
| id | doaj.art-34f78492be1e4e29abf88903851d87be |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-09T10:32:49Z |
| publishDate | 2022-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-34f78492be1e4e29abf88903851d87be2023-12-01T21:07:16ZengMDPI AGJournal of Clinical Medicine2077-03832022-04-01118225010.3390/jcm11082250The Impact of Cardiovascular Risk Factors on the Course of COVID-19Katarzyna Wilk-Sledziewska0Piotr Jan Sielatycki1Natalia Uscinska2Elżbieta Bujno3Mariusz Rosolowski4Katarzyna Kakareko5Rafal Sledziewski6Alicja Rydzewska-Rosolowska7Tomasz Hryszko8Edyta Zbroch9Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, PolandDepartment of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, PolandDepartment of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, PolandDepartment of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, PolandDepartment of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, 15-276 Bialystok, PolandDepartment of Radiology, Medical University of Bialystok, 15-276 Bialystok, Poland2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, 15-276 Bialystok, Poland2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, 15-276 Bialystok, PolandDepartment of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, PolandAim of the study: The aim of our review is to indicate and discuss the impact of cardiovascular risk factors, such as obesity, diabetes, lipid profile, hypertension and smoking on the course and mortality of COVID-19 infection. Background: The coronavirus disease 2019 (COVID-19) pandemic is spreading around the world and becoming a major public health crisis. All coronaviruses are known to affect the cardiovascular system. There is a strong correlation between cardiovascular risk factors and severe clinical complications, including death in COVID-19 patients. All the above-mentioned risk factors are widespread and constitute a significant worldwide health problem. Some of them are modifiable and the awareness of their connection with the COVID-19 progress may have a crucial impact on the current and possible upcoming infection. Data collection: We searched for research papers describing the impact of selected cardiovascular risk factors on the course, severity, complications and mortality of COVID-19 infection form PubMed and Google Scholar databases. Using terms, for example: “COVID-19 cardiovascular disease mortality”, “COVID-19 hypertension/diabetes mellitus/obesity/dyslipidemia”, “cardiovascular risk factors COVID-19 mortality” and other related terms listed in each subtitle. The publications were selected according to the time of their publications between January 2020 and December 2021. From the PubMed database we obtain 1552 results. Further studies were sought by manually searching reference lists of the relevant articles. Relevant articles were selected based on their title, abstract or full text. Articles were excluded if they were clearly related to another subject matter or were not published in English. The types of articles are mainly randomized controlled trial and systematic review. An additional criterion used by researchers was co-morbidities and age of patients in study groups. From a review of the publications, 105 of them were selected for this work with all subheadings included. Findings and Results: The intention of this review was to summarize current knowledge about comorbidities and development of COVID-19 infection. We tried to focus on the course and mortality of the abovementioned virus disease in patients with concomitant CV risk factors. Unfortunately, we were unable to assess the quality of data in screened papers and studies we choose because of the heterogenicity of the groups. The conducted studies had different endpoints and included different groups of patients in terms of nationality, age, race and clinical status. We decide to divide the main subjects of the research into separately described subtitles such as obesity, lipid profile, hypertension, diabetes, smoking. We believe that the studies we included and gathered are very interesting and show modern and present-day clinical data and approaches to COVID-19 infection in specific divisions of patients.https://www.mdpi.com/2077-0383/11/8/2250COVID-19cardiovascularobesitysmokinghypertensionlipid profile |
| spellingShingle | Katarzyna Wilk-Sledziewska Piotr Jan Sielatycki Natalia Uscinska Elżbieta Bujno Mariusz Rosolowski Katarzyna Kakareko Rafal Sledziewski Alicja Rydzewska-Rosolowska Tomasz Hryszko Edyta Zbroch The Impact of Cardiovascular Risk Factors on the Course of COVID-19 Journal of Clinical Medicine COVID-19 cardiovascular obesity smoking hypertension lipid profile |
| title | The Impact of Cardiovascular Risk Factors on the Course of COVID-19 |
| title_full | The Impact of Cardiovascular Risk Factors on the Course of COVID-19 |
| title_fullStr | The Impact of Cardiovascular Risk Factors on the Course of COVID-19 |
| title_full_unstemmed | The Impact of Cardiovascular Risk Factors on the Course of COVID-19 |
| title_short | The Impact of Cardiovascular Risk Factors on the Course of COVID-19 |
| title_sort | impact of cardiovascular risk factors on the course of covid 19 |
| topic | COVID-19 cardiovascular obesity smoking hypertension lipid profile |
| url | https://www.mdpi.com/2077-0383/11/8/2250 |
| work_keys_str_mv | AT katarzynawilksledziewska theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT piotrjansielatycki theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT nataliauscinska theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT elzbietabujno theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT mariuszrosolowski theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT katarzynakakareko theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT rafalsledziewski theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT alicjarydzewskarosolowska theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT tomaszhryszko theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT edytazbroch theimpactofcardiovascularriskfactorsonthecourseofcovid19 AT katarzynawilksledziewska impactofcardiovascularriskfactorsonthecourseofcovid19 AT piotrjansielatycki impactofcardiovascularriskfactorsonthecourseofcovid19 AT nataliauscinska impactofcardiovascularriskfactorsonthecourseofcovid19 AT elzbietabujno impactofcardiovascularriskfactorsonthecourseofcovid19 AT mariuszrosolowski impactofcardiovascularriskfactorsonthecourseofcovid19 AT katarzynakakareko impactofcardiovascularriskfactorsonthecourseofcovid19 AT rafalsledziewski impactofcardiovascularriskfactorsonthecourseofcovid19 AT alicjarydzewskarosolowska impactofcardiovascularriskfactorsonthecourseofcovid19 AT tomaszhryszko impactofcardiovascularriskfactorsonthecourseofcovid19 AT edytazbroch impactofcardiovascularriskfactorsonthecourseofcovid19 |